Matches in Wikidata for { <http://www.wikidata.org/entity/Q93136701> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q93136701 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q93136701 description "scientific article published on 01 July 2019" @default.
- Q93136701 description "wetenschappelijk artikel" @default.
- Q93136701 description "наукова стаття, опублікована 1 липня 2019" @default.
- Q93136701 name "An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma" @default.
- Q93136701 name "An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma" @default.
- Q93136701 type Item @default.
- Q93136701 label "An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma" @default.
- Q93136701 label "An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma" @default.
- Q93136701 prefLabel "An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma" @default.
- Q93136701 prefLabel "An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma" @default.
- Q93136701 P1433 Q93136701-7CA03AC7-891F-4E27-9C4A-6A7BC8EBA9BF @default.
- Q93136701 P1476 Q93136701-DC18FF66-B55B-4C74-9ADF-BCC8EBAC94AC @default.
- Q93136701 P2093 Q93136701-05DC9E99-9709-48AB-A7AB-C36A49811713 @default.
- Q93136701 P2093 Q93136701-2370D7D6-EFC3-4F21-A47E-CCBF60298B10 @default.
- Q93136701 P2093 Q93136701-3050244B-B542-46E0-AFC4-8F744917F587 @default.
- Q93136701 P2093 Q93136701-67D6ABA3-6FA6-4571-B91B-CA3FBED08540 @default.
- Q93136701 P2093 Q93136701-9F258651-5B41-4130-9A10-A6F508DB33F6 @default.
- Q93136701 P2093 Q93136701-CDD4A73B-4A06-4F76-B1A3-260E19AD8A62 @default.
- Q93136701 P275 Q93136701-793e3cc9-2f03-4014-be9d-61612177a803 @default.
- Q93136701 P2860 Q93136701-98014D0B-158A-4260-9411-8186D27C2FBA @default.
- Q93136701 P2860 Q93136701-F3755276-D2A0-46DB-A5B0-D9908FDDD914 @default.
- Q93136701 P304 Q93136701-943C7417-5A65-4580-9A5A-9E5C81905BA7 @default.
- Q93136701 P31 Q93136701-E6261F2E-4D70-4438-AE4B-2D01EF8F6054 @default.
- Q93136701 P356 Q93136701-096405CE-D4E1-42C8-82DA-A21AF0BE6376 @default.
- Q93136701 P433 Q93136701-BE9B2083-7F43-4A95-B728-23DA7FAFAC7D @default.
- Q93136701 P478 Q93136701-245ED76C-F60A-499D-94A3-BD6688618CCC @default.
- Q93136701 P577 Q93136701-7CE8974C-31AC-42EE-9712-57316F1C01D2 @default.
- Q93136701 P6216 Q93136701-6415c068-6e76-4234-ab6e-7b831dc6e11e @default.
- Q93136701 P698 Q93136701-05562FA0-930D-43C1-97E8-82091DEA8006 @default.
- Q93136701 P932 Q93136701-37B16413-7401-40C4-8C31-9450CF161D07 @default.
- Q93136701 P356 SAJC.SAJC_18_19 @default.
- Q93136701 P698 31489287 @default.
- Q93136701 P1433 Q26842041 @default.
- Q93136701 P1476 "An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma" @default.
- Q93136701 P2093 "Abhishek Mahajan" @default.
- Q93136701 P2093 "Amit Joshi" @default.
- Q93136701 P2093 "Kumar Prabhash" @default.
- Q93136701 P2093 "Vanita Noronha" @default.
- Q93136701 P2093 "Vijay Patil" @default.
- Q93136701 P2093 "Vikas T Talreja" @default.
- Q93136701 P275 Q24082749 @default.
- Q93136701 P2860 Q28393456 @default.
- Q93136701 P2860 Q33378691 @default.
- Q93136701 P304 "159" @default.
- Q93136701 P31 Q13442814 @default.
- Q93136701 P356 "10.4103/SAJC.SAJC_18_19" @default.
- Q93136701 P433 "3" @default.
- Q93136701 P478 "8" @default.
- Q93136701 P577 "2019-07-01T00:00:00Z" @default.
- Q93136701 P6216 Q50423863 @default.
- Q93136701 P698 "31489287" @default.
- Q93136701 P932 "6699239" @default.